Indication
Hemorrhagic disease of newborn due to vitamin K deficiency
Hemorrhagic disease of the newborn due to vitamin K deficiency, also termed vitamin K deficiency bleeding in neonates and young infants, is an acquired coagulopathy characterized by an inability to form stable blood clots. Read more about Hemorrhagic disease of newborn due to vitamin K deficiency
20 drugs 14 manufacturers
Drugs that treat it
Common Hemorrhagic disease of newborn due to vitamin K deficiency therapies.
PHYTONADIONE (phytonadione (vit K1))
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHemorrhagic disease of the newborn due to vitamin K deficiency, also termed vitamin K deficiency bleeding in neonates and young infants, is an acquired coagulopathy characterized by an inability to form stable blood clots.
It primarily affects the hematologic system in neonates and early infants due to naturally low neonatal hepatic stores of vitamin K, minimal transplacental transfer, a sterile gut microflora, and low vitamin K concentrations in unsupplemented breast milk.
Pathophysiologically, the deficiency impairs hepatic gamma-carboxylation of the vitamin K–dependent clotting factors (II, VII, IX, and X), resulting in inactive procoagulants, prolonged clotting times, and spontaneous hemorrhages that manifest clinically as cutaneous purpura, umbilical or gastrointestinal bleeding, or life-threatening intracranial hemorrhage.
- nih.gov
Hemorrhagic disease of the newborn due to vitamin K deficiency, also termed vitamin K deficiency bleeding in neonates and young infants, is an acquired coagulopathy characterized by an inability to form stable blood clots Pathophysiologically, the deficiency impairs hepatic gamma-carboxylation of the vitamin K–dependent clotting factors (II, VII, IX, and X), resulting in inactive procoagulants, prolonged clotting times, and spontaneous hemorrhages that manifest clinically as cutaneous purpura, u...
- nih.gov
Hemorrhagic disease of the newborn due to vitamin K deficiency, also termed vitamin K deficiency bleeding in neonates and young infants, is an acquired coagulopathy characterized by an inability to form stable blood clots It primarily affects the hematologic system in neonates and early infants due to naturally low neonatal hepatic stores of vitamin K, minimal transplacental transfer, a sterile gut microflora, and low vitamin K concentrations in unsupplemented breast milk Pathophysiologically, t...
- nih.gov
It primarily affects the hematologic system in neonates and early infants due to naturally low neonatal hepatic stores of vitamin K, minimal transplacental transfer, a sterile gut microflora, and low vitamin K concentrations in unsupplemented breast milk
- nih.gov
It primarily affects the hematologic system in neonates and early infants due to naturally low neonatal hepatic stores of vitamin K, minimal transplacental transfer, a sterile gut microflora, and low vitamin K concentrations in unsupplemented breast milk
Personalize your experience
Follow Hemorrhagic disease of newborn due to vitamin K deficiency and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.